Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr. Martens PLC (DOCS)
The Dr. Martens share price today is 52.80, view LON DOCS stock exchange data. Track the latest Dr. Martens share price with real-time updates on DOCS stock performance including market cap, day range, 52-week range and dividend yield. Access DOCS charts, earnings dates and analyst estimates to support your investment decisions.
52.80
-1.30(-2.40%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
51.00
55.00
52 wk Range
51.00
90.00
Trading near 52-week Low
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
51.0055.00
52 wk Range
51.0090.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DOCS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
89.67
Upside
+69.82%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Why is Dr. Martens stock sliding today?- Investing.com
Why is Dr. Martens stock plunging today?- Investing.com
- Dr Martens receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Why is Dr. Martens stock plunging today?
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
3 Buy
2 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 89.67
(+69.82% Upside)
Dr. Martens PLC Earnings Call Summary for H2/2026
- Dr. Martens missed Q2 FY2026 EPS forecast by 12.6% (4.23p vs 4.84p expected); revenue fell 0.94% short at £442.95M despite 1.04% stock gain.
- Adjusted profit before tax surged 61% YoY to £55M on consumer-first pivot; gross margin improved 1.2% through reduced markdown dependency.
- Americas and APAC regions delivered strong performance while EMEA faced execution challenges; revenue declined 1.4% on constant currency basis.
- Company provided FY2027-2028 EPS guidance of $1.52 and $1.68 respectively; management emphasized premium product expansion and full-price sales focus.
- CEO Wilson cited strategic shift benefits; CFO Mortimer highlighted cost controls positioning company for growth despite macroeconomic and supply chain risks.
Last Updated: 21-05-2026, 10:40 pm
Read Full TranscriptEarnings
Latest Release
12-11-2026
EPS / Forecast
-0.01 / -0.01
Revenue / Forecast
290.4M / 309M
Compare DOCS to Peers and Sector
Metrics to compare | DOCS | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship RelationshipDOCSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.1x | 17.5x | 9.5x | |
PEG Ratio | 0.22 | 0.04 | 0.02 | |
Price/Book | 1.5x | 2.0x | 1.4x | |
Price / LTM Sales | 0.7x | 0.7x | 0.8x | |
Upside (Analyst Target) | 69.8% | 14.7% | 28.7% | |
Fair Value Upside | Unlock | 15.8% | 13.3% | Unlock |
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Dr. Martens (DOCS) Share Price Today?
The Dr. Martens share price today is 52.80.
What is the current Dr. Martens (DOCS) share price and day range?
As of 15-11-2026, the Dr. Martens share price is 52.80, with a previous close of 54.10. The share price has ranged from 51.00 to 55.00 today, while the 52-week range spans from 51.00 to 90.00.
What Is the Dr. Martens Market Cap?
As of today, Dr. Martens market cap is 501.87M.
Does Dr. Martens Pay Dividends? What's The Current Dividend Yield?
The Dr. Martens dividend yield is 4.7%%.
What Is the Dr. Martens (DOCS) Share Price Target?
The average 12-month share price target for Dr. Martens is 89.67, with a high estimate of 141 and a low estimate of 57. 3 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +69.82% Upside potential.
What Is Dr. Martens's Earnings Per Share (TTM)?
The Dr. Martens EPS (TTM) is 0.029.
When Is the Next Dr. Martens Earnings Date?
Dr. Martens will release its next earnings report on 03-06-2027.
From a Technical Analysis Perspective, Is DOCS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Dr. Martens Trade On?
Dr. Martens is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Dr. Martens?
The stock symbol for Dr. Martens is "DOCS."
How Many Times Has Dr. Martens Stock Split?
Dr. Martens has split 0 times.
How Many Employees Does Dr. Martens Have?
Dr. Martens has 3600 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.